Literature DB >> 28052757

Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.

Serghei Malkov1, John A Shepherd2, Christopher G Scott3, Rulla M Tamimi4, Lin Ma5, Kimberly A Bertrand6, Fergus Couch3, Matthew R Jensen3, Amir P Mahmoudzadeh2, Bo Fan2, Aaron Norman3, Kathleen R Brandt3, V Shane Pankratz3, Celine M Vachon3, Karla Kerlikowske5.   

Abstract

Entities:  

Year:  2017        PMID: 28052757      PMCID: PMC5209878          DOI: 10.1186/s13058-016-0797-y

Source DB:  PubMed          Journal:  Breast Cancer Res        ISSN: 1465-5411            Impact factor:   6.466


× No keyword cloud information.

Erratum

After publication of the original article [1], the author noticed some errors to the article [1] which are included in this erratum. All errors reported in this erratum have been updated in the original article [1]. In the ‘Results’ section of the article Abstract, the sentence “Entropy was associated with a decreased risk of breast cancer” should be "Entropy was associated with an increased risk of breast cancer”. In the same section, the variables "FD_TH10", "FD_TH15", "FD_TH60", "FD_TH85", "FD_TH75", and "FD_TH75" should include an additional underscore so they are presented as: "FD_TH_10", "FD_TH_15", "FD_TH_60", "FD_TH_85", "FD_TH_75", and "FD_TH_75", respectively. All variables should be italicized. In the section entitled ‘Breast texture measurements’, the sentence “the image with only constant grayscale pixels has Energy equal to 0" should state "the image with only constant grayscale pixels has Energy equal to 1". In the ‘Results’ section of the article [1], the variable “FD_TH_75” included in sentence: “The top left and bottom left images show a top 20th percent tile value of FD_TH_75” should be included in italics. In the ‘Abbreviations’ section, “BGTDM” should be "NGTDM". The correct version of the ‘Abbreviations’ is included in this erratum and has been updated in the original article [1]. In Table 1, in the column “Texture feature name”, the names of variables should be in italics. In addition in Table 5, in the column “Feature”, all variables should also be included in italics. The revised versions of Tables 1 and 5 are included in this erratum and have been updated in the original article [1].
Table 1

Image texture features that are currently defined for all study participants

Analysis GroupsTexture FeaturesTexture feature nameReference
Gray-level HistogramStandard deviation STD [7, 22, 24–26]
Skewness Skewness
Kurtosis Kurtosis
Balance Balance
Grey-level co-occurrence matrix (GLCM)GLCM Energy Energy [24, 25, 27, 29]
GLCM Entropy Entropy
GLCM Dissimilarity Dissimilarity
GLCM Contrast Contrast
GLCM Homogeneity Homogeneity
GLCM Correlation Correlation
GLCM Mean GLCM Mean
GLCM Variance GLCM Variance
Neighborhood Gray-tone Difference Matrix (NGTDM)NGTDM Coarseness NGTDM Coarseness [24, 28, 29]
NGTDM Contrast NGTDM Contrast
NGTDM Complexity Complexity
NGTDM Strength Strength
NGTDM Busyness Busyness
Edge Frequency AnalysisMean Gradient Mean_Gradient [29]
Fourier Transform Analysis, Power SpectrumRMS FT_RMS [29]
FMP (first moment of power spectrum) FT_FMP
SMP (second moment of power spectrum) FT_SMP
FD from power spectrum exponent FT_FD
Fractal AnalysisIntercept of the plot of the standard deviation of the high frequency image as a function of the size the kernel CD_Yint [29–31]
Continuous Dimension (CD), slope and intercept CD_Slope
HZ_PROJ HZ_PROJ
FD of the standard deviation FD_Sigma
FD of image using thresholds from 5%-85% FD_TH_5: FD_TH_85
FD of the surface of thebreast considering the gray value represent the height FD_CALDWELL
FD, Minkowski method FD_Minkowski
Table 5

Risk associated of either DCIS or Invasive Cancer for each feature

FeatureDCISInvasiveER-ER+
OR (95% CI)OR (95% CI)p-value*p-het**OR (95% CI)OR (95% CI) p-value *p-het**
N case/control 254/1659 908/1659 116/1291 746/1291
FD_TH_75 0.87 (0.74, 1.01)0.87 (0.78, 0.96)0.0100.980.84 (0.67, 1.06)0.88 (0.79, 0.99)0.0480.72
Energy 0.88 (0.76, 1.02)0.88 (0.80, 0.96)0.0110.930.85 (0.69, 1.05)0.86 (0.78, 0.95)0.0090.90
Entropy 1.18 (1.02, 1.38)1.13 (1.03, 1.25)0.0100.601.16 (0.93, 1.44)1.15 (1.03, 1.28)0.0240.96
FD_TH_70 0.85 (0.72, 1.00)0.87 (0.79, 0.97)0.0150.750.84 (0.67, 1.06)0.89 (0.79, 1.00)0.0850.64
FD_TH_80 0.90 (0.77, 1.04)0.89 (0.81, 0.98)0.0340.900.85 (0.68, 1.05)0.89 (0.80, 1.00)0.0660.64
FD_TH_10 1.19 (1.04, 1.38)1.09 (0.99, 1.19)0.0220.211.03 (0.84, 1.26)1.06 (0.96, 1.18)0.4790.75
Kurtosis 0.86 (0.73, 1.00)0.90 (0.81, 0.99)0.0320.580.98 (0.78, 1.22)0.91 (0.81, 1.01)0.2160.53
FD_TH_65 0.84 (0.71, 0.99)0.89 (0.80, 0.99)0.0350.490.83 (0.65, 1.06)0.91 (0.81, 1.03)0.1700.46
FD_Minkowski 0.90 (0.74, 1.08)0.86 (0.77, 0.97)0.0420.710.77 (0.59, 1.01)0.89 (0.78, 1.01)0.0630.32
Busyness 1.15 (1.00, 1.33)1.09 (1.00, 1.19)0.0530.460.92 (0.75, 1.14)1.09 (0.99, 1.21)0.1280.12
Homogeneity 1.05 (0.90, 1.22)1.13 (1.03, 1.24)0.0420.361.06 (0.86, 1.31)1.12 (1.01, 1.24)0.0910.62
Dissimilarity 0.96 (0.83, 1.12)0.89 (0.81, 0.98)0.0570.350.95 (0.77, 1.17)0.89 (0.81, 0.99)0.1100.61
FD_TH_60 0.85 (0.71, 1.02)0.9 (0.8, 1.01)0.0770.560.9 (0.69, 1.15)0.92 (0.81, 1.04)0.3480.85
FD_TH_85 0.92 (0.79, 1.06)0.91 (0.83, 1)0.1300.980.89 (0.72, 1.09)0.91 (0.82, 1.01)0.1730.77
FD_TH_15 1.2 (1.04, 1.39)1.06 (0.97, 1.16)0.0340.090.96 (0.78, 1.18)1.05 (0.95, 1.16)0.5720.43

Results presented as OR per 1 SD in normalized feature after adjustment for age, family history, PD, and study

*p-value refers to 2 degree of freedom to test for evidence of associated with DCIS or invasive cancer

**Heterogeneity p-value to test for differences in effect between tumor subgroups

Image texture features that are currently defined for all study participants Risk associated of either DCIS or Invasive Cancer for each feature Results presented as OR per 1 SD in normalized feature after adjustment for age, family history, PD, and study *p-value refers to 2 degree of freedom to test for evidence of associated with DCIS or invasive cancer **Heterogeneity p-value to test for differences in effect between tumor subgroups
  1 in total

1.  Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status.

Authors:  Serghei Malkov; John A Shepherd; Christopher G Scott; Rulla M Tamimi; Lin Ma; Kimberly A Bertrand; Fergus Couch; Matthew R Jensen; Amir P Mahmoudzadeh; Bo Fan; Aaron Norman; Kathleen R Brandt; V Shane Pankratz; Celine M Vachon; Karla Kerlikowske
Journal:  Breast Cancer Res       Date:  2016-12-06       Impact factor: 6.466

  1 in total
  3 in total

Review 1.  Glucocorticoid Receptor: A Multifaceted Actor in Breast Cancer.

Authors:  Lara Malik Noureddine; Olivier Trédan; Nader Hussein; Bassam Badran; Muriel Le Romancer; Coralie Poulard
Journal:  Int J Mol Sci       Date:  2021-04-24       Impact factor: 5.923

2.  Oxidative Stress Mediates the Fetal Programming of Hypertension by Glucocorticoids.

Authors:  Jeremy Lamothe; Sandhya Khurana; Sujeenthar Tharmalingam; Chad Williamson; Collin J Byrne; Simon J Lees; Neelam Khaper; Aseem Kumar; T C Tai
Journal:  Antioxidants (Basel)       Date:  2021-03-29

3.  Multiplex Patient-Based Drug Response Assay in Pancreatic Ductal Adenocarcinoma.

Authors:  Andrew Armstrong; Muhammad R Haque; Sina Mirbagheri; Usman Barlass; Douglas Z Gilbert; Jaimin Amin; Ajaypal Singh; Ankur Naqib; Faraz Bishehsari
Journal:  Biomedicines       Date:  2021-06-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.